Drug intelligence / Profile preview

ergosterol peroxide

Development stage
Preclinical
Lead developer
Qiqihar Medical University
Modality
Small Molecules
Administration
Oral
01

Overview

Ergosterol peroxide is a naturally occurring steroid derivative and small molecule isolated from various medicinal fungi, most notably *Ganoderma lucidum* (Reishi), as well as yeast, lichens, and sponges. It exhibits a broad spectrum of biological activities, including potent anticancer, anti-inflammatory, antiviral, and antimycobacterial properties. Mechanistically, it has been identified as an inhibitor of glutaminase 1 (GLS1), which disrupts cancer cell metabolism by blocking the conversion of glutamine to glutamate, and as an inhibitor of the sodium/taurocholate cotransporting polypeptide (NTCP), which is a key entry receptor for hepatitis B and D viruses. Preclinical research, primarily conducted by academic institutions such as Qiqihar Medical University and National Chiao Tung University, has demonstrated its efficacy in murine models of triple-negative breast cancer and liver cancer. The compound has shown metabolic stability and a favorable safety profile in animal studies, with no signs of toxicity at doses up to 500 mg/kg.

Other names
5α,8α-epidioxyergosta-6,22-dien-3β-ol5,8-epidioxyergosterolergosterol 5,8-peroxide
02

Targets

CYP51A1 (Sterol 14α-demethylase)GLS1 (Glutaminase 1)NTCP (Na+-taurocholate cotransporting polypeptide)

Beyond the preview

Go deeper on ergosterol peroxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ergosterol peroxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call